BiotechTube

KW-0761

Phase 2Completed
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Adult T-cell Leukemia-lymphoma

Conditions

Adult T-cell Leukemia-lymphoma

Trial Timeline

Jun 1, 2009 → Nov 1, 2010

NCT ID
NCT00920790

About KW-0761

KW-0761 is a phase 2 stage product being developed by Kyowa Kirin for Adult T-cell Leukemia-lymphoma. The current trial status is completed. This product is registered under clinical trial identifier NCT00920790. Target conditions include Adult T-cell Leukemia-lymphoma.

What happened to similar drugs?

9 of 20 similar drugs in Adult T-cell Leukemia-lymphoma were approved

Approved (9) Terminated (2) Active (11)
✅BenralizumabAstraZenecaApproved
✅FluMist + inactivated influenza vaccineAstraZenecaApproved
✅Saizen® solution for injection (referred as Saizen®)MerckApproved
✅Tacrolimus/Sirolimus + Tacrolimus/MMF + Neoral/SirolimusRocheApproved
✅Aztreonam lysineGilead SciencesApproved
✅maraviroc + Raltegravir + Darunavir/ritonavirPfizerApproved
✅SabrilLundbeckApproved

Hype Score Breakdown

Clinical
12
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (5)

NCT IDPhaseStatus
NCT01192984Phase 2Completed
NCT01226472Phase 2Completed
NCT00920790Phase 2Completed
NCT00888927Phase 1/2Completed
NCT00355472Phase 1Completed

Competing Products

20 competing products in Adult T-cell Leukemia-lymphoma

See all competitors
ProductCompanyStageHype Score
BBP-398 + sotorasibBridgeBio PharmaPhase 1
18
Daridorexant + PlaceboIdorsiaPhase 1
23
SON-1010 (IL12-FHAB)Sonnet BioTherapeuticsPhase 1
23
SomatropinEli LillyPhase 3
40
agenT-797MiNK TherapeuticsPhase 1
19
PegilodecakinEli LillyPhase 1
29
eFT226 + Sotorasib + Fulvestrant + Abemaciclib + TrastuzumabeFFECTOR TherapeuticsPhase 1/2
29
Lazertinib(G001) + Lazertinib(G002)YuhanPhase 1
29
Patritumab deruxtecanDaiichi SankyoPhase 2
27
DJ-927 + capecitabineDaiichi SankyoPhase 1
29
Valemetostat TosylateDaiichi SankyoPhase 2
35
RoxadustatAstellas PharmaPhase 1
29
ASP3325 + PlaceboAstellas PharmaPhase 1
29
TRK-100STPAstellas PharmaPhase 1
29
EnsitrelvirShionogiPhase 1
29
E6130 + PlaceboEisaiPhase 1
29
E7389 + E7389 + E7389EisaiPhase 1
29
Eribulin MesylateEisaiPhase 1
29
E2022 + E2022 + E2022 + E2022 + E2022EisaiPhase 1
29
Donepezil Hydrochloride + Donepezil Hydrochloride + Donepezil Hydrochloride + Donepezil HydrochlorideEisaiPhase 1
29